RSS Feeds
Search

Press releases

Press releases

Displaying 1..10 of 11 - per page Next page
Order by
Morphochem names Alfred E. Seidel as CEO. Dr Seidel will drive strategic change at the Company as it advances its products into clinical development. More
Dr David Rees becomes Director of Medicinal Chemistry at Astex More
First part of multi-stage lead generation project, for novel Nitric Oxide synthase inhibitors, now completed More
Morphochem AG and Xenogen Corp. today announced that both companies have entered into a research collaboration to discover targets and develop compounds effective against bacterial biofilms. More
Morphochem and GBF have entered into a research collaboration in the area of cancer research, the objective of which is to develop new therapeutics using tubulysins. More
Launch of new website reflects transition to drug development company More
Morphochem AG, has announced that one of its leading programmes, inhibitors of blood coagulation Factor Xa, led to the identification of novel, orally available anti-thrombotics in in preclinical studies More
Morphochem AG, a leader in the evolutionary discovery of small molecule drugs, has entered into a research collaboration with Novartis wherein Morphochem will apply the MOREsystem, its evolutionary drug discovery engine. More
Morphochem enters into research collaboration with AstraZeneca AB (Sweden) - to apply MOREsystem(tm) drug discovery engine More
Displaying 1..10 of 11 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us